Genus (GNS.L) Stock Analysis & Winston Score

Genus plc is a British biotechnology company that improves farm animals using genetics and science. It sells superior breeding animals and genetic material — mainly semen and embryos — to pig and cattle farmers around the world, helping them produce more meat and milk from each animal. Genus operates two main divisions: PIC (pigs) and ABS (cattle), and it is one of the largest animal genetics companies in the world. Genus makes money by selling breeding stock and genetic doses to farmers on a recurring basis, which creates a steady stream of repeat purchases as farmers continuously need fresh genetic material each season. The company operates globally, with significant revenue from North America, Europe, Latin America, and a growing presence in China. Its main competitive advantage is its large proprietary gene pool, built over decades, which is difficult for rivals to replicate quickly. The biggest growth opportunity — and risk — is its gene-editing program aimed at producing pigs resistant to a costly disease called PRRS, which awaits regulatory approval in key markets.